Proteomic signatures of corona and herpes viral antibodies identify IGDCC4 as a mediator of neurodegeneration

Journal:
Science Advances
Published:
DOI:
10.1126/sciadv.adt7176
Affiliations:
30
Authors:
33
Institutions Authors Share
NIH National Institute on Aging (NIA), United States of America (USA)
9.000000
0.27
Johns Hopkins University (JHU), United States of America (USA)
8.000000
0.24
University of Pennsylvania Health System (UPHS), United States of America (USA)
4.000000
0.12
University of Gothenburg (GU), Sweden
2.166667
0.07
Rush University Medical Center, United States of America (USA)
2.000000
0.06
Vanderbilt University Medical Center (VUMC), United States of America (USA)
2.000000
0.06
NIH National Institute of Neurological Disorders and Stroke (NINDS), United States of America (USA)
1.000000
0.03
NYU Langone Health, United States of America (USA)
1.000000
0.03
Columbia University in the City of New York (CU), United States of America (USA)
0.500000
0.02
Health Sciences, Pitt, United States of America (USA)
0.500000
0.02
Sahlgrenska University Hospital (SU), GU, Sweden
0.416667
0.01
New York Genome Center (NYGC), United States of America (USA)
0.250000
0.01
Columbia University Irving Medical Center (CUIMC), CU, United States of America (USA)
0.250000
0.01
King's College London (KCL), United Kingdom (UK)
0.250000
0.01
NIHR Maudsley Biomedical Research Centre and Dementia Unit (BRC/U), United Kingdom (UK)
0.250000
0.01
Helse Stavanger University Hospital, Norway
0.250000
0.01
Brain and Spine Institute (ICM), France
0.250000
0.01
The First Affiliated Hospital of Anhui University of Science and Technology, China
0.250000
0.01
UCL, United Kingdom (UK)
0.166667
0.01
UK DRI at UCL (UK DRI UCL), United Kingdom (UK)
0.166667
0.01
The Hong Kong University of Science and Technology (HKUST), China
0.166667
0.01
University of Wisconsin Hospitals and Clinics (UW Health), United States of America (USA)
0.166667
0.01